Asensus Surgical to Host Investor Day on February 21, 2023
Asensus Surgical, Inc. (NYSE American: ASXC) announced an Investor Day scheduled for February 21, 2023, at the InterContinental New York Barclay Hotel. The event begins at 11:30 AM EST and will feature a live webcast available on the company’s investor relations page.
Asensus is focused on Performance-Guided Surgery, leveraging its Senhance® Surgical System to enhance surgical outcomes through advanced technologies like machine vision and deep learning. The system aims to address the current challenges in surgical practices, reinforcing the company's commitment to redefining surgical standards.
- None.
- None.
RESEARCH TRIANGLE PARK, N.C., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that the Company will host an Investor Day on Tuesday, February 21, 2023 in New York City.
2023 Investor Day Overview
Date: Tuesday, February 21, 2023
Time: 11:30 AM EST
Location: InterContinental New York Barclay Hotel
A live webcast of the conference presentation will be available online on the investor relations page of the Company’s website at https://ir.asensus.com/events-and-presentations. Replays of the webcasts will be archived on the website.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance® Surgical System powered by the Intelligent Surgical Unit™ (ISU™) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: www.senhance.com/indications. For more information, visit www.asensus.com.
Follow Asensus
Email Alerts: https://ir.asensus.com/email-alerts
LinkedIn: https://www.linkedin.com/company/asensus-surgical-inc
Twitter: https://twitter.com/AsensusSurgical
YouTube: https://www.youtube.com/c/transenterix
Vimeo: https://vimeo.com/asxc
TikTok: https://www.tiktok.com/@asensus_surgical
INVESTOR CONTACT:
Mark Klausner or Mike Vallie, 443-213-0499
invest@asensus.com
MEDIA CONTACT:
Isabella Rodriguez, 708-833-1572
CG Life
irodriguez@cglife.com
FAQ
What is the date of Asensus Surgical's Investor Day 2023?
Where will the Investor Day for Asensus Surgical be held?
What time does the Investor Day for Asensus Surgical start?
Will there be a webcast for Asensus Surgical's Investor Day?
What does Asensus Surgical focus on?
